IL-21 is critical for GVHD in a mouse model

Bone Marrow Transplantation

Volumn 45, Issue 4, 2010, Pages 723-729

  Meguro, A ^a   Ozaki, K ^a   Oh, I ^a   Hatanaka, K ^a   Matsu, H ^a   Tatara, R ^a   Sato, K ^a   Leonard, W J ^b   Ozawa, K ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

GVHD; Hematopoietic SCT; IL 21

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DECOY RECEPTOR 3; INTERLEUKIN 21;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CD4 CD8 RATIO; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; GRAFT VERSUS HOST REACTION; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SPLEEN CELL; WILD TYPE;

ANIMALS; BONE MARROW TRANSPLANTATION; CD4-CD8 RATIO; DISEASE MODELS, ANIMAL; GRAFT VS HOST DISEASE; INTERLEUKINS; KAPLAN-MEIERS ESTIMATE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT;

EID: 77950599836     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.223     Document Type: Article

References (26)

1. Ozaki K, Leonard WJ. Cytokine and cytokine receptor pleiotropy redundancy. J Biol Chem 2002; 277: 29355-29358.
2. Leonard WJ. Cytokines immunodeficiency diseases. Nat Rev Immunol 2001; 1: 200-208.
3. Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS et al. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993; 73: 147-157. (Pubitemid 23115456)
4. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 1995; 181: 1519-1526.
5. Lodolce JP, Boone DL, Chai S, Swain RE, Dassopoulos T, Trettin S et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 1998; 5: 669-676. (Pubitemid 28557595)
6. Ozaki K, Spolski R, Feng CG, Qi CF, Cheng J, Sher Au C et al. A critical role for IL-21 in regulating immunoglobulin production. Science 2002; 298: 1630-1634. (Pubitemid 35387203)
7. Parrish-Novak J, Dillon SR, Nelson A, Hammond A, Sprecher C, Gross JA et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 2000; 408: 57-63.
8. Ozaki K, Kikly K, Michalovich D, Young PR, Leonard WJ. Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc Natl Acad Sci USA 2000; 97: 11439-114344.
9. Brandt K, Bulfone-Paus S, Foster DC, Ruckert R. Interleukin-inhibits dendritic cell activation and maturation. Blood 2003; 102: 4090-4098. (Pubitemid 37486993)
10. Ozaki K, Hishiya A, Hatanaka K, Nakajima H, Wang G, Hwu P et al. Overexpression of IL-21 induces expansion of hematopoietic progenitor cells. Int J Hemat 2006; 84: 224-230. (Pubitemid 44619243)
11. Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007; 8: 967-974. (Pubitemid 47300011)
12. Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, Ma L et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007; 448: 480-483. (Pubitemid 47123514)
13. Korn T, Bettelli E, Gao W, Awasthi A, Jäger A, Strom TB et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007; 448: 484-487. (Pubitemid 47123515)
14. Wurster AL, Rodgers VL, Satoskar AR, Whitters MJ, Young DA, Collins M et al. Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells. J Exp Med 2002; 196: 969-977.
15. Pesce J, Kaviratne M, Ramalingam TR, Thompson RW, Urban Jr JF, Cheever AW et al. The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J Clin Invest 2006; 116: 2044-2055. (Pubitemid 44033328)
16. Frö hlich A, Marsland BJ, Sonderegger I, Kurrer M, Hodge MR, Harris NL et al. IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo. Blood 2007; 109: 2023-2031. (Pubitemid 46348202)
17. Strengell M, Sareneva T, Foster D, Julkunen I, Matikainen S. IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response. J Immunol 2002; 169: 3600-3605.
18. Ozaki K, Spolski R, Ettinger R, Kim HP, Wang G, Qi CF et al. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol 2004; 173: 5361-5371. (Pubitemid 39392119)
19. Bubier JA, Sproule TJ, Foreman O, Spolski R, Shaffer DJ, Morse III HC et al. A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSBYaa mice. Proc Natl Acad Sci USA 2009; 106: 1518-1523.
20. Spolski R, Kashyap M, Robinson C, Yu Z, Leonard WJ. IL-21 signaling is critical for the development of type I diabetes in the NOD mouse. Proc Natl Acad Sci USA 2008; 105: 14028-14033.
21. Sutherland AP, Van Belle T, Wurster AL, Suto A, Michaud M, Zhang D et al. IL-21 is required for the development of type 1 diabetes in NOD mice. Diabetes 2009; 58: 1144-1155.
22. Shlomchik WD. Graft-versus-host disease. Nat Rev Immunol 2007; 7: 340-352. (Pubitemid 46674485)
23. Cooke KR, Kobzik L, Martin TR, Brewer J, Delmonte Jr J, Crawford JM et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 1996; 88: 3230-3239. (Pubitemid 26357409)
24. Graubert TA, DiPersio JF, Russell JH, Ley TJ. Perforin/ granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation. J Clin Invest 1997; 100: 904-911.
25. Tsukada N, Kobata T, Aizawa Y, Yagita H, Okumura K. Graft-versus-leukemia effect and graft-versus-host disease can be differentiated by cytotoxic mechanisms in a murine model of allogeneic bone marrow transplantation. Blood 1999; 93: 2738-2747. (Pubitemid 29181207)
26. Schmaltz C, Alpdogan O, Horndasch KJ, Muriglan SJ, Kappel BJ, Teshima T et al. Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graftversus-host disease and graft-versus-leukemia effect. Blood 2001; 97: 2886-2895.